CDER Plans to Issue Almost 100 New or Revised Draft Guidances in 2018

Drug Industry Daily
A A
CDER published an agenda of 98 upcoming draft guidances for the 2018 calendar year — including new recommendations for developing treatments for Alzheimer’s and amyotrophic lateral sclerosis.

To View This Article:

Login

Subscribe To Drug Industry Daily